Alterra System Plus SAPIEN 3 Valve Triggers More Arrhythmias vs Harmony Valve, but Long-Term Data Are Lacking

Join our community to access additional content!

CRT Community

$0.00

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Join Now!
Already have an account? Login Now

CRT Community Premium

$650.00 annually

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Complimentary subscription to electronic version of the CRM Journal

Access to CRT Meeting Registration Discounts

CRT Premium Content, including on-demand videos and presentation downloads

Join Now!
Already have an account? Login Now
News

Alterra System Plus SAPIEN 3 Valve Triggers More Arrhythmias vs Harmony Valve, but Long-Term Data Are Lacking

Posted: 03/25/2026
Author:
Natalie Morrison, CRTonline.org
News Pulmonic Valve Interventions Medtronic Valve & Structural 2026 News Articles Transcatheteter Pulmonary Valve Replacement

Pulmonary regurgitation patients who received the Alterra Adaptive Pre-stent System with the SAPIEN 3 self-expanding transcatheter pulmonary valve (SETPV) suffered more ventricular arrhythmias (VAs) than those given Harmony SETPVs, a new large multicenter registry analysis found.

Most Viewed Pages

Pulling the Plug and Rolling With the Leak: Occluder Removal and Tootsie Roll to Prevent Interaction

Microplastics and nanoplastics in atheromas and cardiovascular events

Real-World Medicare Data Shows Low Reintervention Rates Through 9 Years in Low-Risk TAVR

PCI has Better QoL Effects vs OMT in Single CTO Patients: Post-Hoc Analysis

Paclitaxel versus sirolimus based balloon angioplasty for in-stent restenosis: A comparison of the AGENT IDE and SELUTION4ISR Randomized Pivotal Controlled Trials

Invalid Configuration Data. Please look into Pipeline and other configurations.

No record found for the searched term.

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Join our community to access additional content!

CRT Community

CRT Community Premium

News

Alterra System Plus SAPIEN 3 Valve Triggers More Arrhythmias vs Harmony Valve, but Long-Term Data Are Lacking

Most Viewed Pages

Explore the Site

Stay Connected